Pelicans are reclaiming a Louisiana island that very nearly vanished. The Houma Navigation Canal Bird Island near Cocodrie had shrunk so badly that less than one-third of its area still offered nesting habitat, but a $40 million restoration has made nearly 100% of the island usable for waterbirds again, at the same time as giving south Louisiana one more line of defence against storm surges. Nola.com https://www.nola.com/news/environment/pelican-island-coastal-restoration-louisiana-bird/article_0c302092-686c-49c3-ae9b-9ffc083dd206.html
#ShareGoodNewsToo
A rebuilt Louisiana island is providing a home for the state bird. 'A win-win.'

The revitalization of the remote island restores a key nesting area for scores of waterbirds, including Louisiana's state bird, the brown pelican.

NOLA.com
Cities can now achieve “what was once thought impossible”: cutting air pollution by 20–45% in little more than a decade. A new analysis has found that 19 cities, including London, San Francisco and Beijing, cut levels of both PM2.5 and nitrogen dioxide (NO2) by more than 20% since 2010, driven by measures such as cycle lanes, electric vehicles and restrictions on polluting traffic. The Guardian
https://www.theguardian.com/environment/2026/mar/12/london-san-francisco-and-beijing-achieve-remarkable-reductions-in-air-pollution
#ShareGoodNewsToo
London, San Francisco and Beijing achieve ‘remarkable reductions’ in air pollution

Cycle lanes, electric cars and other interventions have helped 19 global cities slash levels of pollutants by more than 20%

The Guardian
Cities can now achieve “what was once thought impossible”: cutting air pollution by 20–45% in little more than a decade. 19 cities, including London, San Francisco and Beijing, cut levels of both PM2.5 and nitrogen dioxide (NO2) by more than 20% since 2010. buff.ly/hsm3JlY #ShareGoodNewsToo

London, San Francisco and Beij...
London, San Francisco and Beijing achieve ‘remarkable reductions’ in air pollution

Cycle lanes, electric cars and other interventions have helped 19 global cities slash levels of pollutants by more than 20%

The Guardian
‘Truly spectacular’ drug for sleeping sickness simplifies treatment, raising hopes for eradication. European regulators have approved acoziborole, a new treatment for sleeping sickness that cures the disease with a single oral dose. The drug replaces complex regimens requiring hospitalisation, spinal taps and weeks of monitoring, making treatment far easier in remote regions. Experts say the breakthrough could help eliminate the disease this decade. https://www.science.org/content/article/truly-spectacular-drug-sleeping-sickness-simplifies-treatment-raising-hopes-eradication
#ShareGoodNewsToo
European regulators have approved acoziborole, a new treatment for sleeping sickness that cures the disease with a single oral dose. The drug replaces complex regimens requiring hospitalisation, spinal taps and weeks of monitoring. buff.ly/KX3Ld2B #ShareGoodNewsToo

‘Truly spectacular’ drug for s...
EU moves to end animal testing for detergents and surfactants. Under the revised Detergents Regulation, animal tests for this category will be prohibited from mid-2029, and only scientifically validated non-animal methods will be allowed to assess risks to human health and the environment. Eurogroup for Animals https://www.eurogroupforanimals.org/news/eu-takes-big-step-end-animal-tests-everyday-cleaning-products
#ShareGoodNewsToo
EU takes big step to end animal tests for everyday cleaning products

In a major policy breakthrough for animal welfare and ethical science, the EU has reached a landmark agreement to ban the use of animal testing in the development of detergents and related cleaning products. This decision marks a notable moment in the broader movement towards phasing out harmful animal testing practices across EU chemical laws.

Adult smoking in the United States has dropped below 10% for the first time. New analysis of national survey data found that cigarette use fell from 10.8% of adults in 2023 to 9.9% in 2024 (about 25 million people) down from 42% in 1964. The shift has helped drive a long fall in cancer mortality, with the American Cancer Society estimating reduced smoking prevented nearly four million lung cancer deaths between 1970 and 2022. Gizmodo https://gizmodo.com/americas-smoking-habit-just-hit-a-wild-milestone-that-once-seemed-impossible-2000732807
#ShareGoodNewsToo
America’s Smoking Habit Just Hit a Wild Milestone That Once Seemed Impossible

The adult smoking rate reached a record low in 2024, new research shows.

Gizmodo
Adult smoking in the United States has dropped below 10% for the first time. The shift has helped drive a long fall in cancer mortality, with the American Cancer Society estimating reduced smoking prevented nearly 4 million lung cancer deaths between 1970 and 2022 buff.ly/UzfP4jC #ShareGoodNewsToo

America’s Smoking Habit Just H...
America’s Smoking Habit Just Hit a Wild Milestone That Once Seemed Impossible

The adult smoking rate reached a record low in 2024, new research shows.

Gizmodo
A Japanese company has received the green light to mass-manufacture a treatment for Parkinson’s that transplants stem cells directly into the brain. In a seven-person study no adverse effects were observed and more than half the participants showed some signs of recovery. Because the study was so small, the license is provisional: patients will continue to be monitored and if the drug proves dangerous, it will be withdrawn. https://parkinsonsnewstoday.com/news/japan-grants-conditional-approval-amchepry-parkinsons/
#ShareGoodNewsToo
Japan grants conditional approval to Amchepry for Parkinson’s

Japan granted conditional approval to Amchepry, a stem cell-derived therapy for Parkinson’s disease, based on early clinical trial results

Parkinson's News Today
A Japanese company has received the green light to mass-manufacture a treatment for Parkinson’s that transplants stem cells directly into the brain. A 7-person study no adverse effects were observed and more than half the participants showed some signs of recovery buff.ly/JdSnIAx #ShareGoodNewsToo

Japan grants conditional appro...
Japan grants conditional approval to Amchepry for Parkinson’s

Japan granted conditional approval to Amchepry, a stem cell-derived therapy for Parkinson’s disease, based on early clinical trial results

Parkinson's News Today